Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 111

    1.

    Incidence of ocular morbidity among multibacillary leprosy patients during a 2 year course of multidrug therapy.

    Daniel E, Ffytche TJ, Sundar Rao PS, Kempen JH, Diener-West M, Courtright P.

    Br J Ophthalmol. 2006 May;90(5):568-73.PMID: 16622085 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Incidence of ocular complications in patients with multibacillary leprosy after completion of a 2 year course of multidrug therapy.

    Daniel E, Ffytche TJ, Kempen JH, Rao PS, Diener-West M, Courtright P.

    Br J Ophthalmol. 2006 Aug;90(8):949-54. Epub 2006 May 17.PMID: 16707521 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Iris atrophy in patients with newly diagnosed multibacillary leprosy: at diagnosis, during and after completion of multidrug treatment.

    Daniel E, Sundar Rao PS, Ffytche TJ, Chacko S, Prasanth HR, Courtright P.

    Br J Ophthalmol. 2007 Aug;91(8):1019-22. Epub 2006 Nov 15.PMID: 17108015 [PubMed - indexed for MEDLINE]Related articles

    4.

    Eye disease in multibacillary leprosy patients at the time of their leprosy diagnosis: findings from the Longitudinal Study of Ocular Leprosy (LOSOL) in India, the Philippines and Ethiopia.

    Courtright P, Daniel E, Sundarrao, Ravanes J, Mengistu F, Belachew M, Celloria RV, Ffytche T.

    Lepr Rev. 2002 Sep;73(3):225-38.PMID: 12449887 [PubMed - indexed for MEDLINE]Related articles

    5.

    Lagophthalmos in a multibacillary population under multidrug therapy in the People's Republic of China.

    Courtright P, Lewallen S, Li HY, Hu LF, Yang JW.

    Lepr Rev. 1995 Sep;66(3):214-9.PMID: 7500816 [PubMed - indexed for MEDLINE]Related articles

    6.

    Combined 12-month WHO/MDT MB regimen and Mycobacterium w. vaccine in multibacillary leprosy: a follow-up of 136 patients.

    Kaur I, Dogra S, Kumar B, Radotra BD.

    Int J Lepr Other Mycobact Dis. 2002 Sep;70(3):174-81.PMID: 12483965 [PubMed - indexed for MEDLINE]Related articles

    7.

    Multidrug therapy and eye disease in leprosy: a cross-sectional study in the People's Republic of China.

    Courtright P, Hu LF, Li HY, Lewallen S.

    Int J Epidemiol. 1994 Aug;23(4):835-42.PMID: 8002199 [PubMed - indexed for MEDLINE]Related articles

    8.

    Incidence of acute nerve function impairment and reactions in leprosy: a prospective cohort analysis after 5 years of follow-up.

    Richardus JH, Nicholls PG, Croft RP, Withington SG, Smith WC.

    Int J Epidemiol. 2004 Apr;33(2):337-43.PMID: 15082636 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Ocular complications in newly diagnosed borderline lepromatous and lepromatous leprosy patients: baseline profile of the Indian cohort.

    Daniel E, Koshy S, Rao GS, Rao PS.

    Br J Ophthalmol. 2002 Dec;86(12):1336-40.PMID: 12446359 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Ocular manifestation in treated multibacillary Hansen's disease.

    Parikh R, Thomas S, Muliyil J, Parikh S, Thomas R.

    Ophthalmology. 2009 Nov;116(11):2051-7.e1. Epub 2009 Sep 19.PMID: 19766316 [PubMed - indexed for MEDLINE]Related articles

    11.

    Is leprosy blindness avoidable? The effect of disease type, duration, and treatment on eye damage from leprosy in Uganda.

    Waddell KM, Saunderson PR.

    Br J Ophthalmol. 1995 Mar;79(3):250-6.PMID: 7703204 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Long-term follow up of multibacillary leprosy patients with high BI treated with WHO/MDT regimen for a fixed duration of two years.

    Shaw IN, Natrajan MM, Rao GS, Jesudasan K, Christian M, Kavitha M.

    Int J Lepr Other Mycobact Dis. 2000 Dec;68(4):405-9.PMID: 11332283 [PubMed - indexed for MEDLINE]Related articles

    15.

    Nerve function impairment in leprosy at diagnosis and at completion of MDT: a retrospective cohort study of 786 patients in Bangladesh.

    Richardus JH, Finlay KM, Croft RP, Smith WC.

    Lepr Rev. 1996 Dec;67(4):297-305.PMID: 9033200 [PubMed - indexed for MEDLINE]Related articles

    16.

    Daily multidrug therapy for leprosy; results of a fourteen-year experience.

    de Carsalade GY, Wallach D, Spindler E, Pennec J, Cottenot F, Flageul B.

    Int J Lepr Other Mycobact Dis. 1997 Mar;65(1):37-44.PMID: 9207752 [PubMed - indexed for MEDLINE]Related articles

    17.

    Ocular complications in incident relapsed borderline lepromatous and lepromatous leprosy patients in south India.

    Daniel E, Koshy S, Joseph GA, Rao PS.

    Indian J Ophthalmol. 2003 Jun;51(2):155-9.PMID: 12831146 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Comparative study of uniform-MDT and WHO MDT in Pauci and Multi bacillary leprosy patients over 24 months of observation.

    Rao PN, Suneetha S, Pratap DV.

    Lepr Rev. 2009 Jun;80(2):143-55.PMID: 19743618 [PubMed - indexed for MEDLINE]Related articles

    19.

    Long-term efficacy of 2 year WHO multiple drug therapy (MDT) in multibacillary (MB) leprosy patients.

    Cellona RV, Balagon MF, dela Cruz EC, Burgos JA, Abalos RM, Walsh GP, Topolski R, Gelber RH, Walsh DS.

    Int J Lepr Other Mycobact Dis. 2003 Dec;71(4):308-19.PMID: 14763888 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data